FMP

FMP

Enter

ORPH - Orphazyme A/S

Valuation of Orphazyme A/S(ORPH), Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerativ

Valuation Date:

Dec 31, 1969 7:00 PM

Share Price on Valuation Date

$0.87

Stock Beta

0.80232

Shares Outstanding

0

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep